202 related articles for article (PubMed ID: 21533120)
21. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
[TBL] [Abstract][Full Text] [Related]
22. A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia.
Balakumar P; Mahadevan N; Sambathkumar R
Curr Mol Pharmacol; 2019; 12(3):195-201. PubMed ID: 30636619
[TBL] [Abstract][Full Text] [Related]
23. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Evans JL; Lin JJ; Goldfine ID
Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.
Rakhshandehroo M; Hooiveld G; Müller M; Kersten S
PLoS One; 2009 Aug; 4(8):e6796. PubMed ID: 19710929
[TBL] [Abstract][Full Text] [Related]
25. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
[TBL] [Abstract][Full Text] [Related]
26. Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition.
Tian S; Wang R; Chen S; He J; Zheng W; Li Y
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641558
[TBL] [Abstract][Full Text] [Related]
27. Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.
Szalowska E; van der Burg B; Man HY; Hendriksen PJ; Peijnenburg AA
PLoS One; 2014; 9(1):e86795. PubMed ID: 24489787
[TBL] [Abstract][Full Text] [Related]
28. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
Fiévet C; Fruchart JC; Staels B
Curr Opin Pharmacol; 2006 Dec; 6(6):606-14. PubMed ID: 16973418
[TBL] [Abstract][Full Text] [Related]
29. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
31. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
32. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
Gani OA
Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
[TBL] [Abstract][Full Text] [Related]
33. A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma.
Jeong HW; Lee JW; Kim WS; Choe SS; Kim KH; Park HS; Shin HJ; Lee GY; Shin D; Lee H; Lee JH; Choi EB; Lee HK; Chung H; Park SB; Park KS; Kim HS; Ro S; Kim JB
Diabetes; 2011 Feb; 60(2):496-506. PubMed ID: 21270261
[TBL] [Abstract][Full Text] [Related]
34. Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function.
Cabezas F; Lagos J; Céspedes C; Vio CP; Bronfman M; Marzolo MP
PLoS One; 2011 Feb; 6(2):e16794. PubMed ID: 21311715
[TBL] [Abstract][Full Text] [Related]
35. Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes.
Kandel BA; Thomas M; Winter S; Damm G; Seehofer D; Burk O; Schwab M; Zanger UM
Biochim Biophys Acta; 2016 Sep; 1859(9):1218-1227. PubMed ID: 26994748
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Nie M; Corbett L; Knox AJ; Pang L
J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
[TBL] [Abstract][Full Text] [Related]
37. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
38. PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.
Eastham LL; Mills CN; Niles RM
Pharm Res; 2008 Jun; 25(6):1327-33. PubMed ID: 18172578
[TBL] [Abstract][Full Text] [Related]
39. PPARα, PPARγ and SREBP-1 pathways mediated waterborne iron (Fe)-induced reduction in hepatic lipid deposition of javelin goby Synechogobius hasta.
Chen GH; Luo Z; Chen F; Shi X; Song YF; You WJ; Liu X
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jul; 197():8-18. PubMed ID: 28411055
[TBL] [Abstract][Full Text] [Related]
40. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload.
Madec S; Cerec V; Plée-Gautier E; Antoun J; Glaise D; Salaun JP; Guguen-Guillouzo C; Corlu A
Drug Metab Dispos; 2011 Oct; 39(10):1987-96. PubMed ID: 21778351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
